Suchergebnisse - "Downey, Louise"

PubPharm (5)

1

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) : two randomised, double-masked, phase 3, non-inferiority trials

enthalten in: Lancet (London, England) | 2022

von Heier, J. | Khanani, A. | Quezada Ruiz, C. | +115

CommentIn: Lancet. 2022 Feb 19;399(10326):697-699. - PMID 35085501

2

Previous Intravitreal Therapy Is Associated with Increased Risk of Posterior Capsule Rupture during Cataract Surgery

enthalten in: Ophthalmology | 2016

von Lee, A. | Day, A. | Egan, C. | +23

3

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment : 18-Month, Multicenter, Phase IIIB RELIGHT Study

enthalten in: Ophthalmology | 2015

von Pearce, I. | Banerjee, S. | Burton, B. | +11

4

UK AMD EMR USERS GROUP REPORT V : benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

enthalten in: The British journal of ophthalmology | 2015

von Lee, A. | Lee, C. | Butt, T. | +34

5

The neovascular age-related macular degeneration database : multicenter study of 92 976 ranibizumab injections: report 1: visual acuity

enthalten in: Ophthalmology | 2014

von Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group | Tufail, A. | Xing, W. | +15

CommentIn: Eye (Lond). 2023 Dec;37(17):3521-3522. - PMID 37142778

1
[1]